Therapeutic targeting of tumor growth and angiogenesis with a novel anti-S100A4 monoclonal antibody
about
The missing link: does tunnelling nanotube-based supercellularity provide a new understanding of chronic and lifestyle diseases?Melanoma Brain Metastasis: Mechanisms, Models, and MedicineS100A4 and its role in metastasis – computational integration of data on biological networks.S100P antibody-mediated therapy as a new promising strategy for the treatment of pancreatic cancer.The characterization of a novel monoclonal antibody against CD93 unveils a new antiangiogenic target.S100A4 is upregulated in proliferative diabetic retinopathy and correlates with markers of angiogenesis and fibrogenesis.RAGE mediates S100A7-induced breast cancer growth and metastasis by modulating the tumor microenvironmentThe S100A4 D10V polymorphism is related to cell migration ability but not drug resistance in gastric cancer cells.S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinase.S100A4-neutralizing antibody suppresses spontaneous tumor progression, pre-metastatic niche formation and alters T-cell polarization balanceGene expression profiling identifies microphthalmia-associated transcription factor (MITF) and Dickkopf-1 (DKK1) as regulators of microenvironment-driven alterations in melanoma phenotypeS100 proteins in cancer.Silencing of S100A4, a metastasis-associated protein, inhibits retinal neovascularization via the downregulation of BDNF in oxygen-induced ischaemic retinopathy.S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDA-approved anti-helminthic agent niclosamideS100 protein family in human cancer.Retrospective Proteomic Screening of 100 Breast Cancer Tissues.RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis.Metastasis-inducing proteins are widely expressed in human brain metastases and associated with intracranial progression and radiation responseS100A4 in cancer progression and metastasis: A systematic review.Ousting RAGE in melanoma: A viable therapeutic target?Expression and Functional Analysis of Tumor-Related Factor S100A4 in Antler Stem Cells.S100A7: from mechanism to cancer therapy.Molecular factors regulating E-cadherin expression in urothelial bladder cancer and their correlations with the clinicopathological features.
P2860
Q26747455-D59CE3CE-225E-4DB4-B2BB-FE1B2EE89DF9Q28069421-8C0C4491-DEBA-4867-B04C-DD748035844CQ30977149-22814370-5D89-4891-9270-556C7204A095Q33685170-B3D3532F-A29E-42D4-A168-2977AE99B707Q33757101-8A23D4C0-3B83-449E-BC69-519D2C6D42B0Q34161174-1D722108-F264-4E5D-AE35-B72C6A0F3AF1Q34457327-3F0D6D98-0D9A-4687-A707-530D05E5E335Q34556703-67A78E14-32E4-4F04-A199-7EDE739BDB21Q35079996-F1C364F7-2023-4D82-BED6-237571AC9482Q35104378-CBFA6191-9748-4DAB-ACA5-8E440644B9A6Q35147858-B75E17AB-776A-4E27-9145-6E864516A4B5Q35206368-8E4AD9A3-CA0A-412B-9FB2-1D1553C98A34Q37000724-E5014AFA-23D3-47DE-A00E-9DAB2CF0DE5CQ37376360-C09A8E9C-FCC4-4EFE-8E74-3ADCB0EC42B1Q37650123-110C4B12-D964-4354-9CBD-3D62096A9451Q38689543-0509ED28-2049-45E9-B94E-0F49230F3DC7Q38982380-87DDE799-43D0-44FD-ABDC-40CBAF2FDA73Q41512797-2CD2C2CA-1C1E-4404-B22E-57D5BB07653BQ42700673-73A5FFEF-D21F-4283-B149-4222B58E4A41Q47593410-CDEEFFBE-D450-45CD-8190-93C73D43023FQ47918002-28A55AEA-F354-49EE-BF21-A84B17B878BDQ47927472-E6A66ADB-B20D-4498-A628-80EF301C061CQ47951789-8AC8DC39-8410-4825-AE4C-CE561A9DE6E9
P2860
Therapeutic targeting of tumor growth and angiogenesis with a novel anti-S100A4 monoclonal antibody
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Therapeutic targeting of tumor ...... nti-S100A4 monoclonal antibody
@ast
Therapeutic targeting of tumor ...... nti-S100A4 monoclonal antibody
@en
Therapeutic targeting of tumor ...... nti-S100A4 monoclonal antibody
@en-gb
Therapeutic targeting of tumor ...... nti-S100A4 monoclonal antibody
@nl
type
label
Therapeutic targeting of tumor ...... nti-S100A4 monoclonal antibody
@ast
Therapeutic targeting of tumor ...... nti-S100A4 monoclonal antibody
@en
Therapeutic targeting of tumor ...... nti-S100A4 monoclonal antibody
@en-gb
Therapeutic targeting of tumor ...... nti-S100A4 monoclonal antibody
@nl
prefLabel
Therapeutic targeting of tumor ...... nti-S100A4 monoclonal antibody
@ast
Therapeutic targeting of tumor ...... nti-S100A4 monoclonal antibody
@en
Therapeutic targeting of tumor ...... nti-S100A4 monoclonal antibody
@en-gb
Therapeutic targeting of tumor ...... nti-S100A4 monoclonal antibody
@nl
P2093
P2860
P50
P3181
P1433
P1476
Therapeutic targeting of tumor ...... nti-S100A4 monoclonal antibody
@en
P2093
Francesc Blasco
Jaume Adan
Josep Maria Martinez
Laura Padilla
Laura Rodríguez
Rosa Hervas
Sheila Dakhel
Silvia Coma
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0072480
P407
P577
2013-09-04T00:00:00Z